Methods. 2008 Jan;44(1):55-60.

Inhibition of microRNA with antisense oligonucleotides.

Source

Isis Pharmaceuticals and Regulus Therapeutics, 1896 Rutherford Road, Carlsbad, CA 92008, USA. cesau@regulusrx.com

Abstract

Antisense inhibition of microRNA (miRNA) function has been an important tool for uncovering miRNA biology. Chemical modification of anti-miRNA oligonucleotides (AMOs) is necessary to improve affinity for target miRNA, stabilize the AMO to nuclease degradation, and to promote tissue uptake for in vivo delivery. Here I summarize the work done to evaluate the effectiveness of various chemically modified AMOs for use in cultured cells and rodent models, and outline important issues to consider when inhibiting miRNAs with antisense oligonucleotides.

PMID:: 18158133; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Supplemental Content

Related citations

A single anti-microRNA antisense oligodeoxyribonucleotide (AMO) targeting multiple microRNAs offers an improved approach for microRNA interference. [Nucleic Acids Res. 2009]
A single anti-microRNA antisense oligodeoxyribonucleotide (AMO) targeting multiple microRNAs offers an improved approach for microRNA interference.
Lu Y, Xiao J, Lin H, Bai Y, Luo X, Wang Z, Yang B. Nucleic Acids Res. 2009 Feb; 37(3):e24. Epub 2009 Jan 9.
Potent inhibition of microRNA in vivo without degradation. [Nucleic Acids Res. 2009]
Potent inhibition of microRNA in vivo without degradation.
Davis S, Propp S, Freier SM, Jones LE, Serra MJ, Kinberger G, Bhat B, Swayze EE, Bennett CF, Esau C. Nucleic Acids Res. 2009 Jan; 37(1):70-7. Epub 2008 Nov 16.
LNA-modified oligonucleotides mediate specific inhibition of microRNA function. [Gene. 2006]
LNA-modified oligonucleotides mediate specific inhibition of microRNA function.
Ørom UA, Kauppinen S, Lund AH. Gene. 2006 May 10; 372:137-41. Epub 2006 Feb 24.
Review MicroRNAs as targets for antisense-based therapeutics. [Expert Opin Biol Ther. 2008]
Review MicroRNAs as targets for antisense-based therapeutics.
Stenvang J, Kauppinen S. Expert Opin Biol Ther. 2008 Jan; 8(1):59-81.
Review Robust and specific inhibition of microRNAs in Caenorhabditis elegans. [J Biol. 2010]
Review Robust and specific inhibition of microRNAs in Caenorhabditis elegans.
Kundu ST, Slack FJ. J Biol. 2010; 9(3):20. Epub 2010 Apr 1.

See reviews... See all...

Cited by 18 PubMed Central articles

Targeting microRNA-122 to Treat Hepatitis C Virus Infection. [Viruses. 2010]
Targeting microRNA-122 to Treat Hepatitis C Virus Infection.
Jopling CL. Viruses. 2010 Jul; 2(7):1382-93. Epub 2010 Jul 5.
A Potential of microRNAs for High-Content Screening. [J Nucleic Acids. 2011]
A Potential of microRNAs for High-Content Screening.
Serva A, Claas C, Starkuviene V. J Nucleic Acids. 2011; 2011:870903. Epub 2011 Sep 14.
Overexpression of the lung cancer-prognostic miR-146b microRNAs has a minimal and negative effect on the malignant phenotype of A549 lung cancer cells. [PLoS One. 2011]
Overexpression of the lung cancer-prognostic miR-146b microRNAs has a minimal and negative effect on the malignant phenotype of A549 lung cancer cells.
Patnaik SK, Kannisto E, Mallick R, Yendamuri S. PLoS One. 2011; 6(7):e22379. Epub 2011 Jul 18.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Inhibition of microRNA with antisense oligonucleotides.
Inhibition of microRNA with antisense oligonucleotides.
Methods. 2008 Jan ;44(1):55-60.

PubMed
Fusion to Listeriolysin O and delivery by Listeria monocytogenes enhances the im...
Fusion to Listeriolysin O and delivery by Listeria monocytogenes enhances the immunogenicity of HER-2/neu and reveals subdominant epitopes in the FVB/N mouse.
J Immunol. 2005 Sep 15 ;175(6):3663-73.

PubMed
Listeria-based HPV-16 E7 vaccines limit autochthonous tumor growth in a transgen...
Listeria-based HPV-16 E7 vaccines limit autochthonous tumor growth in a transgenic mouse model for HPV-16 transformed tumors.
Vaccine. 2008 Sep 26 ;26(41):5315-20. Epub 2008 Aug 3 .

PubMed
Adjuvant properties of listeriolysin O protein in a DNA vaccination strategy.
Adjuvant properties of listeriolysin O protein in a DNA vaccination strategy.
Cancer Immunol Immunother. 2007 Jun ;56(6):797-806. Epub 2006 Nov 11 .

PubMed
High efficacy of a Listeria-based vaccine against metastatic breast cancer revea...
High efficacy of a Listeria-based vaccine against metastatic breast cancer reveals a dual mode of action.
Cancer Res. 2009 Jul 15 ;69(14):5860-6. Epub 2009 Jul 7 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: